Teva Pharmaceutical Industries (WBO:TEVA) Shares Buyback Ratio % : -1.09 (As of May. 17, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Teva Pharmaceutical Industries Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Teva Pharmaceutical Industries's current shares buyback ratio was -1.09%.

Teva Pharmaceutical Industries Shares Buyback Ratio % Historical Data

The historical data trend for Teva Pharmaceutical Industries's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Shares Buyback Ratio % Chart

Teva Pharmaceutical Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Shares Buyback Ratio %

Get a 7-Day Free Trial

-0.26

-0.40

-0.62

-0.69

-0.92

Teva Pharmaceutical Industries Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-0.86	-0.02	-0.03	-0.01	-1.03

Teva Pharmaceutical Industries Shares Buyback Ratio % Calculation

Teva Pharmaceutical Industries's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2022 )	-	Shares Outstanding (EOP) (A: Dec. 2023 ))	/	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	(1110.9	-	1121.09)	/	1110.9
	=	-0.92%

Teva Pharmaceutical Industries's Shares Buyback Ratio for the quarter that ended in Mar. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Mar. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(1121.09	-	1132.64)	/	1121.09
	=	-1.03%

Teva Pharmaceutical Industries Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Teva Pharmaceutical Industries (WBO:TEVA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (WBO:TEVA) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

TEVJF:USA TEVA:USA TEVA:Mexico TEVA:Israel 0LER:UK TEV:Germany T1EV34:Brazil

Address

124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020

Website

https://www.tevapharm.com

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.